Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).
AuteursMalorni L, Tyekucheva S, Gombos A, Hasler-Strub U, Zamagni C, Chakiba-Brugère C, Colleoni M, Mueller A, Minisini AM, Taylor D, Salmon JP, Gallerani E, Cariello A, Fontana A, Roschitzki-Voser H, Kammler R, Ruepp B, Loi S, Viale G, Regan MM, Brain E, Biganzoli L
Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer.
AuteursKwong JCC, Al-Daqqaq Z, Chelliahpillai Y, Lee S, Kim K, Ringa M, Feifer A, Lajkosz K, Wettstein MS, Chan A, Lee T, Nguyen M, Kassouf W, Black PC, Breau RH, Lodde M, Fairey A, Lattouf JB, Jeldres C, Rendon R, Alimohamed N, Fleshner NE, Diamand R, Gontero P, Sylvester RJ, van Rhijn BWG, Kamat AM, Johnson AEW, Zlotta AR, Kulkarni GS
Interpretation of the association between thyroid peroxidase antibodies and thyroid function during pregnancy: An individual participant data meta-analysis.
AuteursLiu Y, Osinga JAJ, Feldt-Rasmussen U, Vrijkotte TGM, Taylor PN, Aminorroaya A, Ashoor G, Bliddal S, Chen LM, Vaidya B, Palomaki GE, Ghafoor F, López-Bermejo A, Pop VJM, Itoh S, Tao FB, Mosso L, Männistö T, Poppe KG, Pearce EN, Chatzi L, Walsh JP, Popova P, Benhalima K, Nelson SM, Kianpour M, Nicolaides KH, Lu X, Hattersley AT, D'Alton ME, Pirzada A, Bassols J, Broeren MAC, Kishi R, Huang K, Vecchiola A, Boucai L, Vääräsmäki M, Suvanto E, Oken E, Vafeiadi M, Brown SJ, Kleynen P, Grineva EN, Mathieu C, Peeters RP, Derakhshan A, Korevaar TIM
